Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | -10.00% | -10.00% | 0.00% |
Valuation
Fiscal Period: Januari | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Capitalization 1 | 68.87 | 16.68 | 6.746 | 3.484 |
Enterprise Value (EV) 1 | 61.89 | 16.78 | 9.835 | 12.81 |
P/E ratio | -4.43 x | -2 x | -1 x | -0.52 x |
Yield | - | - | - | - |
Capitalization / Revenue | 17.9 x | 1.73 x | 0.44 x | 0.18 x |
EV / Revenue | 16.1 x | 1.74 x | 0.63 x | 0.67 x |
EV / EBITDA | -88.3 x | -2.75 x | -2.23 x | -2.97 x |
EV / FCF | -77,448,384 x | -12,075,818 x | -3,519,045 x | -1,810,998 x |
FCF Yield | -0% | -0% | -0% | -0% |
Price to Book | 8.07 x | 4.09 x | -3.61 x | -0.59 x |
Nbr of stocks (in thousands) | 81,020 | 83,410 | 84,330 | 87,099 |
Reference price 2 | 0.8500 | 0.2000 | 0.0800 | 0.0400 |
Announcement Date | 5/31/21 | 5/31/22 | 6/1/23 | 4/30/24 |
Income Statement Evolution (Annual data)
Fiscal Period: Januari | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales 1 | 2.925 | 3.617 | 3.852 | 9.639 | 15.49 | 19.14 |
EBITDA 1 | 0.7783 | 0.2232 | -0.7009 | -6.104 | -4.412 | -4.31 |
EBIT 1 | 0.754 | 0.1531 | -0.8054 | -6.549 | -5.199 | -5.201 |
Operating Margin | 25.77% | 4.23% | -20.91% | -67.95% | -33.57% | -27.16% |
Earnings before Tax (EBT) 1 | 2.781 | -1.38 | -10.29 | -8.233 | -6.989 | -7.442 |
Net income 1 | 2.107 | -1.356 | -9.903 | -7.808 | -6.903 | -6.636 |
Net margin | 72.05% | -37.5% | -257.05% | -81% | -44.57% | -34.66% |
EPS 2 | 0.6322 | -0.4069 | -0.1918 | -0.1000 | -0.0800 | -0.0776 |
Free Cash Flow | - | -0.5587 | -0.7991 | -1.389 | -2.795 | -7.073 |
FCF margin | - | -15.45% | -20.74% | -14.41% | -18.04% | -36.94% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/24/20 | 9/24/20 | 5/31/21 | 5/31/22 | 6/1/23 | 4/30/24 |
Balance Sheet Analysis
Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.04 | 1.1 | - | 0.09 | 3.09 | 9.32 |
Net Cash position 1 | - | - | 6.98 | - | - | - |
Leverage (Debt/EBITDA) | 0.0487 x | 4.925 x | - | -0.0153 x | -0.6999 x | -2.163 x |
Free Cash Flow | - | -0.56 | -0.8 | -1.39 | -2.79 | -7.07 |
ROE (net income / shareholders' equity) | - | 314% | -268% | -127% | -623% | 170% |
ROA (Net income/ Total Assets) | - | 3.99% | -8.16% | -43.6% | -44.5% | -36.9% |
Assets 1 | - | -33.98 | 121.4 | 17.92 | 15.5 | 18 |
Book Value Per Share 2 | 0.0800 | -0.1100 | 0.1100 | 0.0500 | -0.0200 | -0.0700 |
Cash Flow per Share 2 | 0.1400 | - | 0.0900 | 0.0100 | 0.0200 | 0.0400 |
Capex 1 | 0.27 | 0.26 | 0.5 | 0.95 | 2.59 | 4.09 |
Capex / Sales | 9.37% | 7.06% | 12.97% | 9.87% | 16.7% | 21.36% |
Announcement Date | 9/24/20 | 9/24/20 | 5/31/21 | 5/31/22 | 6/1/23 | 4/30/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.86M | |
+17.18% | 83.07B | |
-28.48% | 70.89B | |
+5.21% | 28.32B | |
-7.44% | 17.73B | |
+1.71% | 17.43B | |
+2.10% | 15.64B | |
+7.02% | 13.46B | |
+64.96% | 12.69B | |
+6.85% | 12.82B |
- Stock Market
- Equities
- JNH Stock
- Financials Jack Nathan Medical Corp.